Skip to main content

Table 3 Frequencies of various adjunct treatments for severe sepsis during the first 7 days after the ICU admission

From: Characteristics, treatments, and outcomes of severe sepsis of 3195 ICU-treated adult patients throughout Japan during 2011–2013

Adjunct treatments

 

 DIC treatments

1498 (47%)

  Antithrombin

990 (31%)

  Thrombomodulin

856 (27%)

   Co-administration of antithrombin and thrombomodulin

496 (16%)

  Protease inhibitors

392 (12%)

  Heparinoids

167 (5%)

 Immunoglobulin

976 (31%)

 Low-dose steroids

777 (24%)

 Renal replacement therapy

890 (28%)

 Non-renal indication renal replacement therapy

266 (8%)

 Polymyxin B-direct hemoperfusion

692 (22%)

  1. Data are presented as number (percentage)
  2. DIC disseminated intravascular coagulation, ICU intensive care unit